Why Can’t Hyper-Partisans Admit TrumpRx Is Dramatically Slashing Drug Costs?
The article discusses the impact of TrumpRx on prescription drug costs, arguing that it has significantly lowered prices for various medications. It criticizes partisan opposition to the program, suggesting that the results speak for themselves despite political bias. The author highlights the negotiation strategies used by Trump to achieve these cost reductions without expanding government bureaucracy.
- ▪TrumpRx has reduced the price of the drug Pristiq from $435 to $200.
- ▪Ngenla, a human growth hormone, now costs $2,217, down from $4,434.
- ▪Xeljanz is available for $1,518, a reduction from $2,277.
- ▪Orencia SC's price has dropped from $6,070 to $3,660.
- ▪The program now covers over 600 generic drugs, benefiting Americans across various income levels.
Opening excerpt (first ~120 words) tap to expand
Why Can’t Hyper-Partisans Admit TrumpRx Is Dramatically Slashing Drug Costs? By RedState Guest Editorial | 6:00 AM on May 30, 2026 The opinions expressed by contributors are their own and do not necessarily represent the views of RedState.com. AP Photo/Julio Cortez, File By Carole Dykhouse, BSNLeave it to the hyper-partisans at the Daily Kos to turn a winning bipartisan issue into a political referendum. On Wednesday, the outlet argued that TrumpRx.gov, the president’s signature healthcare achievement, is not lowering drug prices like the president has stated. Advertisement googletag.cmd.push(function () { googletag.display("div-gpt-300x250_2"); //googletag.pubads().refresh([gptAdSlot["div-gpt-300x250_2"]]) }); The Kos is dead wrong.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at RedState.
Discussion
0 commentsMore from RedState
